Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 34A (ANKRD34A) is a protein encoded by the ANKRD34A gene on chromosome 1. It contains ankyrin repeat domains, which are typically involved in protein–protein interactions but have wide-ranging cellular roles. ANKRD34A is a protein-coding gene, and one of its known disease associations is with autism spectrum disorder. It is predicted to be active in specific cellular substructures called pi-bodies, though the detailed function of ANKRD34A remains unclear. There are no established drugs or therapeutic strategies directly targeting this protein, nor is there substantial evidence that it acts as a therapeutic target in current clinical practice. The ankyrin repeat domain is a common protein motif involved in diverse protein–protein interactions across many biological processes, but ANKRD34A’s specific molecular and cellular roles are poorly characterized. No published data currently link ANKRD34A to cancer, inflammation, neurodegeneration, or other major pathologies beyond the limited mention in autism spectrum disorder. There is no evidence ANKRD34A acts as a receptor, enzyme, transporter, or classical therapeutic target. No known drugs interact with ANKRD34A, nor are any mechanisms of action described for drugs modulating this protein. ANKRD34A is a poorly characterized ankyrin repeat domain-containing protein associated with autism spectrum disorder but is not currently regarded as a therapeutic target or the focus of pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 34A (ANKRD34A).